Search Results - "S.  A.  Tyulandin"

Comparative assessment of the estrogen receptor β expression in the tissues of non-small cell lung carcinoma and lung metastases of tumors of other primary localizations by Bogush, T. A., Shaturova, A. S., Dudko, E. A., Bogush, E. A., Polotsky, B. E., Tyulandin, S. A., Davydov, M. I.

Get full text

Optimal number of lymph nodes to be examined in stage II colon cancer by Fedyanin, M. Yu, Tryakin, A. A., Bulanov, A. A., Gordeev, S. S., Kuzmichev, D. V., Mamedli, Z. Z., Kozlov, N. A., Tyulandin, S. A.

“…Objective: to determine the minimum number of lymph nodes (LN) required for accurate prediction of overall survival in patients with stage II colon cancer and…”
Get full text

Study of FGFR2 status in gastric cancer by immunohistochemistry and fluorescent in situ hybridization by Raskin, G A, Mukhina, M S, Kravtsova, E D, Tsimafeyeu, I V, Tyulandin, S A, Belyak, N P, Kleshchev, M A, Orlova, R V

“…Assessment of FGFR2 status in gastric cancer is an important task, without clarification of which it is impossible to identify a cohort of patients in whom the…”
Get more information

Factors associated with the efficiency of maintenance therapy in patients with metastatic colorectal cancer by Fedyanin, M. Yu, Tryakin, A. A., Polyanskaya, E. M., Pokataev, I. A., Sheina, O. V., Kozlov, N. A., Strogonova, A. M., Gordeev, S. S., Kuz’michev, D. V., Aliev, V. A., Sagaydak, I. V., Rasulov, S. A., Tyulandin, S. A.

“…Objective: to evaluate tolerability and efficacy of maintenance treatment in the absence of progression after 16 weeks of first-line therapy in patients with…”
Get full text

OVARIAN DYSGERMINOMAS: TREATMENT EXPERIENCE OF THE N.N.BLOKHIN CRC RAMS by O. N. Streltzova, M. Yu. Fedyanin, A. A. Tryakin, A. A. Bulanov, V. V. Zhordania, S. A. Tyulandin

“…This is a retrospective review of treatment results of 35 patients with dysgerminomas in the Departments of Clinical Pharmacology and Gynecology, N.N.Blokhin…”
Get full text

Comparative assessment of the estrogen receptor [beta] expression in the tissues of non-small cell lung carcinoma and lung metastases of tumors of other primary localizations by Bogush, T A, Shaturova, A S, Dudko, E A, Bogush, E A, Polotsky, B E, Tyulandin, S A, Davydov, M I

“…In the present study, a comparative quantitative estimation of the level, intensity, and frequency of the ER expression in NSCLC tissues and also in lung…”
Get full text

Efficacy and toxicity of aflibercept and bevacizumab in combination with FOLFIRI in second‑line therapy for metastatic colon cancer: a retrospective multicenter study by M.   Yu. Fedyanin, L.  Yu.  Vladimirova, V.  A.  Chubenko, L.   A. Zagorskaya, A.  V.  Belyaeva, O.  L.  Fakhrutdinova, S.  A.  Belukhin, A.   S. Zhabina, L.   V. Khalikova, L.  V.  Bolotina, R.   V. Orlova, F.  V.  Moiseenko, G.   Z. Mukhametshina, A.  I.  Khasanova, A.  V.  Belonogov, Kh.  S.  Musaeva, O.  Yu.  Novikova, I.  Yu.  Stradaeva, I.  L.  Popova, S.  P.  Erdniev, A.  K.  Ivanova, A.  V.  Androsova, P.  S.  Feoktistova, E.  S.  Kuzmina, E.   V. Karabina, O.  V.  Nekrasova, O.  V.  Sekhina, A.   A. Mishchenko, L.  A.  Mukova, B.  Kh.  Kertiev, G.  I.  Kosar, S.   N. Osodoeva, A.  I.  Kats, R.  R.  Malina, M.  A.  Lyadova, A.  A.  Tryakin, S.  A.  Tyulandin

“…Objective: to compare the efficacy and toxicity of aflibercept and bevacizumab in combination with fOLfIRI in secondline therapy for patients with metastatic…”
Get full text